Very important and practically oriented paper Nice overview of advantages and limitations A must read for anybody who treats these patients To view or add a comment, sign in GLP-1RAs Show Significant Liver and Metabolic Benefits in MASLD A new systematic review and meta-analysis of 32 randomized controlled trials reveals that GLP-1 receptor agonists (GLP-1RAs) significantly improve liver and metabolic outcomes in patients with Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD), far outperforming DPP-4 inhibitors, which showed minimal effects beyond glycemic control
Zepbound may offer advantages for insulin resistance due to its dual hormone action
A Morgan Stanley AlphaWise survey of senior human resources executives showed that the percentage of employers covering GLP-1s for obesity rose from 44% in 2024 to 48% last year, with respondents projecting it to reach 65% by 2027
To be eligible for the Bridge program, you have to have Part D prescription drug coverage through Medicare, either one that you buy directly or one thats included in a Medicare Advantage plan, or a Medicare Special Needs Plan
For weight loss, the medication acts primarily in your brain, binding to crucial receptors responsible for appetite signaling and satiety, helping to curb cravings
If you're ready to move from forum speculation to an actual protocol, the place to start is a consultation with Healthspan's clinical team through the Topical Rapamycin+ for Hair program